Sources | Names Used |
---|---|
CTRPv2 | BRD-K04800985 |
PharmacoGx | BRD-K04800985 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FIGNL1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
mRNA | ERGIC2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
mRNA | RP11-111H13.1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
mRNA | SPRYD3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
mRNA | C2orf49 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
mRNA | PPARGC1A | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | GCA | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
mRNA | SYT13 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
mRNA | EGF | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
mRNA | ATP6V1C2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |